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Abstract
Manganese superoxide dismutase (MnSOD), a foremost antioxidant enzyme, plays a key role in angiogenesis. Barley-derived (1.3) b-D-glucan
(b-D-glucan) is a natural water-soluble polysaccharide with antioxidant properties. To explore the effects of b-D-glucan on MnSOD-related
angiogenesis under oxidative stress, we tested epigenetic mechanisms underlying modulation of MnSOD level in human umbilical vein endothe-
lial cells (HUVECs) and angiogenesis in vitro and in vivo. Long-term treatment of HUVECs with 3% w/v b-D-glucan significantly increased the
level of MnSOD by 200%  2% compared to control and by 50%  4% compared to untreated H2O2-stressed cells. b-D-glucan-treated
HUVECs displayed greater angiogenic ability. In vivo, 24 hrs-treatment with 3% w/v b-D-glucan rescued vasculogenesis in Tg (kdrl: EGFP)
s843Tg zebrafish embryos exposed to oxidative microenvironment. HUVECs overexpressing MnSOD demonstrated an increased activity of
endothelial nitric oxide synthase (eNOS), reduced load of superoxide anion (O2
) and an increased survival under oxidative stress. In addition,
b-D-glucan prevented the rise of hypoxia inducible factor (HIF)1-a under oxidative stress. The level of histone H4 acetylation was significantly
increased by b-D-glucan. Increasing histone acetylation by sodium butyrate, an inhibitor of class I histone deacetylases (HDACs I), did not
activate MnSOD-related angiogenesis and did not impair b-D-glucan effects. In conclusion, 3% w/v b-D-glucan activates endothelial expres-
sion of MnSOD independent of histone acetylation level, thereby leading to adequate removal of O2
, cell survival and angiogenic response
to oxidative stress. The identification of dietary b-D-glucan as activator of MnSOD-related angiogenesis might lead to the development of
nutritional approaches for the prevention of ischemic remodelling and heart failure.
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Introduction
In humans, the chronic exposure to reactive oxygen species (ROS) is
a major risk factor for the impairment of endothelial function [1] and
angiogenesis [2], which are both essential in self-repair ability of
ischemic heart [3]. Even if ROS activates angiogenesis [2], compel-
ling evidence indicates that the endothelial dysfunction because of
superoxide anion (O2
) overload represents a mechanism for deregu-
lated capillary formation after ischemia [4]. The safe and effective
modulation of ROS-driven angiogenesis is still a challenging achieve-
ment, despite significant advances in the past two decades. High lev-
els of the manganese superoxide dismutase (MnSOD), a major
antioxidant enzyme, enhance the endothelial resistance to oxidative
stress [5, 6] and angiogenesis via the scavenging mitochondrial
O2
 [7, 8]. Thus, MnSOD is a promising candidate target for modula-
tion of ROS-induced angiogenesis. To date, cellular MnSOD levels are
significantly increased by a gene therapy approach [9, 10] or via
treatment with histone deacetylases (HDAC) inhibitors leading to
cardioprotection through histone acetylation [11], which allows the
expression of anti-apoptotic and angiogenic paracrine factors in vitro
and in vivo [12]. However, a natural activator of MnSOD-related
angiogenesis under oxidative stress is more desirable.
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Barley-derived (1.3) beta-D-glucan (b-D-glucan), a natural water-
soluble chain of D-glucose monomers linked by b-glycosidic bonds
[13], lowers either oxidative stress [14] or serum cholesterol level
in a dose-dependent manner [15]. The daily intake of b-D-glucan
(1.5–4%) similarly induces the above-mentioned benefits in animal
models and humans [16, 17]. To date, it is unknown whether
b-D-glucan promotes the MnSOD expression and the angiogenic
ability of mature endothelial cells. Despite some controversial preli-
minary evidence [18], it has been suggested that long-term treat-
ment with b-D-glucan enhances MnSOD-related angiogenesis under
oxidative stress. For this purpose, we used the combination of two
gold standard angiogenic tests, such as the in vitro human umbilical
vein endothelial cells (HUVECs) matrigel assay [12, 19, 20] and the
in vivo zebrafish angiogenesis assay [21, 22].
Materials and methods
Chemicals
Barley-derived (1.3) b-D-glucan, hydrogen peroxide (H2O2) and sodium
butyrate (NaBu) were purchased from Sigma-Aldrich Chemical Co (MO,
USA).
Endothelial cell cultures
Human umbilical vein endothelial cells (Cambrex Bio Science Inc, Walk-
ersville, MD, USA) and human cardiac microvascular endothelial cells
(HMVEC-C, Lonza, Milan, Italy) were cultured in endothelial growth
medium (EGM-2 medium from Lonza) at 37°C in a humidified atmo-
sphere of 5% CO2. Cells were exposed to the culture medium with 10%
foetal bovine serum for at least 1 day before experiments. All assays
were conducted using low cell passage cells (2–5 passages).
Cell viability assay
Low-dose treatment with H2O2 (50 lM) was used to induce chronic oxi-
dative stress on HUVECs [23, 24]. After 24 hrs of exposure to H2O2
with or without 3% w/v b-D-glucan, cell viability was assessed by the
Trypan blue dye exclusion test, as previously described [25]. When indi-
cated, H2O2-stressed HUVECs were cultured in the presence of NaBu, a
specific inhibitor of class I HDAC (reviewed in [26]), at rising concentra-
tions (5–500 lM). All measurements were performed in triplicate.
Dihydroethidium staining
Endothelial superoxide anion generation was determined by staining of
HUVECs with fluorescent-labelled dihydroethidium (DHE; Invitrogen, CA,
USA), according to manufacturer’s instructions.
Superoxide anion assay
Superoxide anion levels were assessed using a Superoxide Anion Assay
Kit (Sigma-Aldrich Chemical Co), according to manufacturer’s
instruction relative to testing changes in superoxide anion production
directly on intact cells.
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Fig. 1 b-D-glucan treatment promotes endothelial cell survival and MnSOD expression under chronic oxidative stress. (A) HUVECs survival after
24 hrs treatment with 50 lM H2O2, alone or in combination with 3% b-D-glucan. Untreated and unstressed cells were used as control. (B) Quantifi-
cation of the relative intensity of fluorescence in DHE-positive cells, compared to control condition. (C) Quantification of the relative intensity of
luminescence in cells producing superoxide anion, compared with control condition. (D) Representative western blot bands for MnSOD and GAPDH.
(E) Measurement of the level of MnSOD expression normalized over loading control (GAPDH). (mean  SD; n = 4) *P < 0.05 versus control;
§P < 0.05 versus H2O2.
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Western blotting
Equal amounts of protein extracted with RIPA buffer from cell pellets were
processed for western blotting assay. The ratio of phospho-Ser1177eNOS
(p-eNOS) and total eNOS, a hallmark of eNOS activity [27], was then
determined as previously described [28]. Protein bands on immunoblots
were quantified using ImageJ software.
Nitric oxide detection
DAF-FM staining for the determination of intracellular nitric oxide bio-
availability in human endothelial cells was performed as described else-
where [29].
In vitro angiogenesis assay
The in vitro angiogenesis assay was performed as described previously
[12, 19, 20]. Analysis of capillary-like tube formation was performed
using gel-precoated wells (Cultrex Basement Membrane Extract, BME,
Thema). Image analysis was performed by ImageJ software.
Zebrafish lines, imaging and stages
Zebrafish transgenic embryos Tg (kdrl:EGFP) s843Tg (expressing
EGFP in the vascular system) were raised and maintained under
standard laboratory conditions [30] as described elsewhere [31]. The
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Fig. 2 b-D-glucan treatment increases
eNOS phosphorylation and histone H4
acetylation in viable endothelial cells. (A)
Representative western blot bands for
HSP70, HIF1-a, p-AKT, AKT, p-eNOS,
eNOS and GAPDH in each experimental
condition. (B) Measurement of the level of
HSP70, HIF1-a, AKT, eNOS expression
normalized over loading control (GAPDH).
Phosphorylation level of eNOS and AKT
was quantified normalizing the amount
of phosphorylated protein over total
protein: p-eNOS/eNOS and p-AKT/AKT.
(mean  SD; n = 4) *P < 0.05 versus
control.
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oxidative stress was induced in vivo by treatment with PMA, an ago-
nist of protein kinase C [32]. Imaging was performed on zebrafish
embryos at 24 hpf (hours post-fertilization). Investigation was
approved by the Animal Care Committee of the Italian Ministry of
Health in accordance with the European law (EU 63-2010) and with
the Guide for the Care and Use of Laboratory Animals published by
the US National Institutes of Health (NIH Publication No. 85–23,
revised 1996).
Statistical analysis
The statistical analysis was performed using GraphPad Prism ver. 5.
All results are presented as mean  SD. Statistical comparisons
were made by ANOVA and Dunnett’s Multiple Comparison Test was
used as the post-hoc test. P < 0.05 was considered statistically
significant.
Results
b-D-glucan treatment promotes endothelial cell
survival and MnSOD expression under chronic
oxidative stress
As shown in Figure 1A, the treatment with 3% b-D-glucan signifi-
cantly increased the number of viable cells under oxidative
stress.
The measure of fluorescence in the nuclei of cells positive
for dEDT staining showed that b-D-glucan normalized the ROS
load of stressed cells (Fig. 1B) while such amount was signifi-
cantly increased in the absence of treatment. In addition, we
confirmed that b-D-glucan reduced the total O2
 in HUVECs
(Fig. 1C) and HMVEC-C (Fig. S1). b-D-glucan significantly
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Fig. 3 b-D-glucan treatment increases nitric oxide generation in stressed endothelial cells. (A) Representative images of DAF staining of HUVECs at
rest or with H2O2, in the presence of b-D-glucan or vehicle. (B) Quantification of the relative intensity of fluorescence in DAF-FM diacetate positive
cells at rest or during oxidative stress (H2O2), in the presence of b-D-glucan or vehicle. (mean  SD; n = 3) *P < 0.05 versus control.
Fig. 4 b-D-glucan treatment increases histone H4 acetylation and promotes human capillary formation in vitro. (A) Representative western blot bands
for histone H4 (H4) and acetylated histone H4 (Acetyl-H4) in each experimental condition. Measurement of the level of H4 expression normalized
over loading control (GAPDH). Acetylation level of H4 was quantified normalizing the amount of Acetyl-H4 protein over total protein. (B and C)
Representative images of tube formation from HUVECs without exogenous growth factors. (D and E) Representative images of tube formation from
HUVECs with exogenous growth factors. (F) Measure of total length of tubes from HUVECs without exogenous growth factors. (G) Measure of total
length of tubes from HUVECs with exogenous growth factors. Intrinsic tube formation ability was tested alone (control) or with 3% b-D-glucan; at
rest (left side) or during oxidative stress (stress, right side) (mean  SD; n = 4) *P < 0.05 versus control; **P < 0.01 versus control; §P < 0.05
versus H2O2.
230 ª 2014 The Authors.
Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
β β
A
B
ED
C
Without growth factors
Re
st
St
re
ss
Without growth factors
ControlControl β-D-glucan β-D-glucan
With growth factors
Re
st
St
re
ss
With growth factors
ControlControl β-D-glucan β-D-glucan
F
G
ª 2014 The Authors.
Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
231
J. Cell. Mol. Med. Vol 19, No 1, 2015
enhanced the protein expression of MnSOD in viable cells
exposed to normal microenvironment. The level of MnSOD in
b-D-glucan-treated cells exposed to H2O2 was tendentially
higher compared to untreated stressed cells (Fig. 1C, quantified
in 1D).
b-D-glucan treatment increases eNOS
phosphorylation and histone H4 acetylation in
viable endothelial cells
b-D-glucan treatment of stressed cells caused a significant
increase in p-eNOS/eNOS ratio without affecting the level of
p-AKT, AKT, and heat shock protein-70 (HSP-70; Fig. 2A, quanti-
fied in 2B). We detected a significant increase in nitric oxide pro-
duction in stressed b-D-glucan-treated HUVECs (Fig. 3) and
HMVEC-C (Fig. S1). Interestingly, the rise of hypoxia inducible
factor (HIF)-1a level was prevented in H2O2-stressed cells treated
with b-D-glucan (representative blots shown in Fig. 2A, quantified
in 2B). As shown in Figure 4A, the level of H4 acetylation in b-
D-glucan-treated cells was significantly higher than untreated cells
under normal and oxidative microenvironment.
b-D-glucan treatment promotes human capillary
formation in vitro
b-D-glucan increased the tube formation activity of normal endothelial
cells cultured without exogenous endothelial growth factors (Fig. 4B).
As shown in Figure 4B (right panel), b-D-glucan induced a significant
slight increase in ROS-driven angiogenesis.
In the presence of exogenous endothelial growth factors (Fig. 4C),
the formation of capillaries from normal or H2O2-stressed HUVECs was
significantly increased by treatment with 3% b-D-glucan. The addition of
exogenous growth factors in the culture medium did not increase the
magnitude of ROS-driven angiogenesis (Fig. 4C, right panel) nor
enhances the pro-angiogenic effect of b-D-glucan. In addition, the treat-
ment with a similar dose of b-D-glucan significantly increased the angio-
genic ability of HMVEC-C in vitro (Fig. S1).
b-D-glucan treatment rescues the vasculogenic
activity under oxidative stress in vivo
The chronic exposure to PMA alone significantly halted the formation
of the caudal artery at 24 hpf, measured as an increase in the distance
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Fig. 5 b-D-glucan treatment rescues the vasculogenic activity under chronic oxidative stress in vivo. (A) Representative images of Zebrafish transgenic Tg
(kdrl: EGFP)s843Tg embryos at 24 hpf (hours post-fertilization), alone (control) or treated at 70% epiboly stage with 3% b-D-glucan, PMA, and PMA+3%
b-D-glucan. Brackets: normal caudal plexus; stars: injured caudal plexus; scale bar 100 lm. (B) At each experimental condition, representative images of
caudal view of embryos, at 24 hpf. DLAV: dorsal longitudinal anastomotic vessel (CVP, caudal vein plexus). White arrow: end of DLAV; scale bar 150 lm.
(C) Measurement of the distance between the end of DLAV and the tip of CPV at each experimental condition. *P < 0.05 versus control.
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between the end of the dorsal longitudinal anastomotic vessel (DLAV)
and the caudal vein plexus (CVP) of Tg (kdrl: EGFP)s843Tg embryos
(Fig. 5). In an additional group, 3% b-D-glucan counteracted the ROS-
induced vascular toxicity and preserved the vasculogenic activity
essential to lead the normal formation of the caudal artery (Fig. 5A,
quantified in Fig. 5B). No impairment of vasculogenesis was detected
in samples from b-D-glucan -treated embryos under normal conditions.
b-D-glucan modulation of cell viability and
MnSOD expression does not rely on histone
acetylation
In both microenvironmental conditions, 24 hrs treatment with 50 and
500 lM of NaBu had a slight but significant adverse effect on cell
survival (Fig. 6A); although, 5 lM of NaBu did not affect the cell via-
bility. As shown in Figure 6B and quantified in Figure 6C, NaBu
increased the level of H4 acetylation in a dose-dependent manner
without changing the endothelial MnSOD expression level in all the
experimental conditions.
The simultaneous 24 hrs treatment of HUVECs with 3% w/v b-
D-glucan and NaBu 5 lM did not interfere with b-D-glucan effects
on cell viability (data not shown) and MnSOD expression (Fig. 7A,
quantified in Fig. 7B, upper panel) even in the presence of high
level of H4 acetylation (Fig. 7A, quantified in Fig. 7B, lower panel).
Finally, the treatment of cells with 3% w/v b-D-glucan, alone or in
combination with NaBu 5 lM, prevented the rise of O2
 level
(Fig. 8A for quantification of dEDT staining; Fig. 8B for representa-
tive images).
b-D-glucan modulation of human capillary
formation does not rely on histone acetylation
Even if the 24 hrs treatment with NaBu 5 lM did not attenuate the
angiogenic ability of HUVECs, it slightly increased capillary formation
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Fig. 6 NaBu does not increase Endothelial
MnSOD expression. (A) HUVECs survival
after 24 hrs treatment with 50 lM H2O2,
alone or with increasing dose of sodium
butyrate (NaBu) ranging from 5 to
500 lM. (B) Representative western blot
bands for MnSOD, histone H4 (H4), acety-
lated histone H4 (Ac-H4) and GAPDH in
each experimental condition. (C) Measure-
ment of the level of H4 expression nor-
malized over loading control (GAPDH).
Acetylation level of H4 was quantified nor-
malizing the amount of Acetyl-H4 protein
over total protein. (D) Measurement of the
level of MnSOD expression normalized
over loading control (GAPDH). nt: control
(mean  SD; n = 4) *P < 0.05 versus
control; **P < 0.01 versus control:
***P < 0.001 versus control; §P < 0.05
versus H2O2.
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from HUVECs cultured without growth factors and stress (Fig. 9A).
We found that the inhibition of HDAC activity did not affect the
proangiogenic effect of b-D-glucan. As shown in Figure 9B, the
co-treatment of cells with b-D-glucan and NaBu 5 lM increased
the capillary forming activity of normal HUVECs cultured in complete
medium.
Discussion
The enhancement of endogenous angiogenic activity may hold prom-
ises for restoring adequate myocardial perfusion in ischemic heart. It
is emerging that the optimization of antioxidant gene expression may
promote mature capillary formation [33]. MnSOD is the most effec-
tive antioxidant enzyme [34] that protects myocardium via scaveng-
ing mitochondrial O2
 [35]. Cardiac overexpression of MnSOD limits
cardiac cell loss and renders the heart more resistant to the oxidative
burst [36]. In addition, MnSOD gene transfer restores endothelial
function through increasing activity of eNOS [37], which exerts direct
pro-angiogenic effect [38]. Consistent with these observations, it has
been suggested that increased MnSOD expression might enhance
ROS-driven angiogenesis.
A recent study suggested that the use of natural molecules could
be sufficient to induce endothelial MnSOD expression [39]. Hence,
the identification of novel dietary compounds able either to increase
MnSOD level or to enhance angiogenesis may prove rewarding in
sight of therapeutic myocardial angiogenesis, therefore, avoiding
invasive approaches.
We provided evidence that barley b-D-glucan is an active natural
enhancer of the angiogenic potential of ROS-exposed endothelial cells
related to increased MnSOD expression.
The treatment of monolayered H2O2-stressed HUVECs with 3%
w/v b-D-glucan increased MnSOD level without reducing the expres-
sion of HSP70, a stress protein sufficient to active MnSOD [40]. In
agreement with previous studies, the increase in the expression of
MnSOD was useful to improve its enzymatic activity [41], which
prevails over that of SOD1 in attenuating superoxide anion level [42].
The rise of b-D-glucan-induced MnSOD expression, which reduced the
intracellular load of O2
 in stressed endothelial cells, was related to
the normal level of HIF-1a, thus rendering the cells more resistant to
the oxidative burst. In fact, the reduction in O2
 level suppressed the
expression of HIF-1a [43], which plays a role in promoting cell death
by autophagy [44]. On the other hand, the eNOS activation via phos-
phorylation of serine 1177 was enhanced by b-D-glucan without
involving the activation of AKT/PKB, which is an established eNOS
activator [27, 45]. Increased nitric oxide generation contributes to neu-
tralize O2
 in stressed cells [46], and the endothelial eNOS activation
is also regulated in an AKT-independent manner [47]. In our study, the
nitric oxide synthesis was significantly increased in stressed b-D-glu-
can- treated adult and newborn endothelial cells. Therefore, we have
shown that b-D-glucan-induced MnSOD up-regulation encompasses
both endothelial pro-survival features, by preventing the increase in
HIF-1a expression, and the potential to reduce superoxide anion level,
by activating eNOS in an AKT-independent manner.
Taking into account that the b-D-glucan effects were considerably
more accentuated under oxidative stress than in normal conditions,
we tested whether the increased MnSOD expression affects the
angiogenic response to ROS. Notably, b-D-glucan-treated endothelial
cells generated more vessels either with or without exogenous growth
factors in the medium. In addition, we found that the extent of
increasing tube formation from cultured HMVEC-C treated by similar
dose of b-D-glucan was smaller than HUVECs (Fig. S1). Our data were
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Fig. 7 NaBu does not affect b-D-glucan-induced MnSOD up-regulation
under chronic oxidative stress. (A) Representative western blot bands
for MnSOD, histone H4 (H4), acetylated histone H4 (Ac-H4) and GAP-
DH in each experimental condition. (B) Measurement of the level of
MnSOD and H4 expression normalized over loading control (GAPDH).
Acetylation level of H4 was quantified normalizing the amount of Ace-
tyl-H4 protein over total protein. Cells were exposed to H2O2 for
24 hrs, alone or in combination with 3% b-D-glucan, NaBu (5 lM), or
both. Unstressed and untreated cells were used as control
(mean  SD; n = 4). *P < 0.05 versus control; §P < 0.05 versus
H2O2.
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Fig. 8 NaBu does not affect b-D-glucan-
induced superoxide anion down-regulation
under chronic oxidative stress. (A) Quanti-
fication of the relative intensity of fluores-
cence in DHE positive cells in each
experimental condition at rest or during
oxidative stress (H2O2). (B) Representative
images of DHE staining of HUVECs at rest
or with H2O2, in the presence of either
b-D-glucan, NaBu (5 lM), or both
(mean  SD; n = 4). *P < 0.05 versus
control; ***P < 0.001 versus control;
§P < 0.05 versus H2O2.
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Fig. 9 NaBu does not affect b-D-glucan-induced capillary formation under chronic oxidative stress. (A) In vitro angiogenesis assay without exoge-
nous growth factors. Intrinsic tube formation ability was tested, alone (untreated) or with 3% b-D-glucan, NaBu (5 lM,) or both; at rest (left side)
or during oxidative stress (right side). (C) In vitro angiogenesis assay with exogenous growth factors. Tube formation ability was tested, alone
(untreated) or in combination with 3% b-D-glucan, NaBu (5 lM), or both; at rest (left side) or during oxidative stress (right side; mean  SD;
n = 4). *P < 0.05 versus control; §P < 0.05 versus b-D-glucan.
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in accordance with a previous study showing lower angiogenic
response to exogenous factors of adult endothelial cells compared to
HUVECs [48]. The finding that b-D-glucan-treated cells exhibited a
significant yield of angiogenesis in the absence of either exogenous
growth factors or oxidative stress prompted the hypothesis that b-D-
glucan exerts a direct pro-angiogenic activity. It is known that endo-
thelial cells form a dense capillary network regardless the conven-
tional paracrine growth factors [19, 49, 50]. Since MnSOD
overexpression promotes endothelial cell sprouting [41], it is conceiv-
able that b-D-glucan-induced angiogenesis depends upon MnSOD
level. In addition, we cannot exclude the direct pro-angiogenic effect
also exerted by NO generated from eNOS [38], which is activated by
MnSOD [37].
To confirm in vitro data, we performed in vivo experiments using
transgenic zebrafish embryos. In an additional experiment, we treated
PMA-exposed embryos with 3% w/v b-D-glucan. Prolonged PMA
treatment inhibits VEGF expression [51] and VEGF-induced angiogen-
esis by down-regulation of PKC [52]. In our model, long-term PMA
exposure remarkably hampered the development of the dorsal longi-
tudinal anastomotic vessel and the simultaneous treatment of PMA-
exposed embryos with b-D-glucan rescued the physiological vascular
development. b-D-glucan did not affect vessel density of healthy
embryos.
Unraveling mechanisms would offer options to better modulate
MnSOD-related angiogenesis by b-D-glucan. Endothelial cells express
dectin-1, a C-type lectin-like receptor, [53] and b-D-glucan effects are
suppressed with Dectin-1-specific blocking monoclonal antibody
[54]. It suggests that the engagement of Dectin-1 might represent a
major initial step in endothelial gene expression modulation. It is
worth noticing that b-D-glucan-treated HUVECs showed a consistent
histone acetylation level, yet it was higher in H2O2-exposed cells. Our
results prompted the hypothesis that the binding of Dectin-1 to b-D-
glucan induces MnSOD expression via histone acetylation. Shimazu
et al. [55], in fact, have shown that histone acetylation as a result of
inhibition of class I HDAC increases MnSOD expression. In our
model, with rising of histone acetylation level, the MnSOD expression
was unaffected by increasing doses of NaBu, a class I HDAC inhibitor.
At higher doses of NaBu (50 or 500 lM), we detected cell death in
the presence of higher level of histone acetylation and O2
 (data not
shown). Conversely, the exposure of HUVECs to a lower dose of NaBu
(5 lM) added to complete medium enhanced angiogenesis. Nonethe-
less, the b-D-glucan effects were unaffected by co-treatment with
5 lM NaBu.
Our study verified that the b-D-glucan-induced rise of MnSOD
level and tube formation was not because of inhibition of class I
HDAC. Even if the pro-angiogenic effect of water-soluble b-D-glucan
was independent of HDAC activity, we cannot exclude that higher
doses of b-D-glucan may promote cell death similarly to NaBu. In fact,
a previous study demonstrated that treatment of HUVECs with a cock-
tail containing a higher dose of fungal b-D-glucan exhibited an anti-
angiogenic effect [18].
Studies are in progress to further dissect the panel of signaling
pathways modulating gene profile recruited by barley b-D-glucan.
In conclusion, we identified barley b-D-glucan as natural activator
of MnSOD expression and the angiogenic ability of ROS-exposed
endothelial cells regardless histone acetylation. Since mature endo-
thelial cells exhibit intrinsically lower expression of MnSOD compared
to endothelial progenitor cells [56], our results assume significance
to develop b-D-glucan-based approaches of therapeutic angiogenesis
for the prevention of heart failure.
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